Vident Investment Advisory, LLC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 225 filers reported holding MYRIAD GENETICS INC in Q3 2017. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
Vident Investment Advisory, LLC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q1 2023$325,405
+59.5%
14,008
+90.0%
0.01%
+120.0%
Q4 2021$204,000
-0.5%
7,374
+10.2%
0.01%
-16.7%
Q2 2021$205,000
-93.6%
6,689
-92.2%
0.01%
-95.3%
Q2 2018$3,222,000
+30.8%
86,231
+1.5%
0.13%
+27.0%
Q1 2018$2,464,000
-37.7%
84,938
-26.2%
0.10%
-43.8%
Q4 2017$3,954,000
+1.1%
115,121
+6.5%
0.18%
-16.0%
Q3 2017$3,911,000
-2.4%
108,092
-30.3%
0.21%
-36.1%
Q2 2017$4,007,000
+36.9%
155,067
+1.7%
0.33%
+14.1%
Q1 2017$2,927,000
+88.2%
152,426
+200.0%
0.29%
+32.9%
Q2 2016$1,555,000
-58.4%
50,802
-49.1%
0.22%
-5.2%
Q1 2016$3,738,000
+77.4%
99,882
+104.6%
0.23%
-13.2%
Q4 2015$2,107,000
+185.5%
48,817
+147.9%
0.27%
+160.8%
Q3 2015$738,000
+29.5%
19,689
+17.3%
0.10%
+34.2%
Q2 2015$570,000
+1.4%
16,781
+5.7%
0.08%
-32.7%
Q1 2015$562,000
+17.6%
15,873
+13.0%
0.11%
-29.8%
Q4 2014$478,00014,0470.16%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$90,850,0003.94%
Altium Capital Management LP 221,000$4,016,0001.61%
DISCIPLINED GROWTH INVESTORS INC /MN 1,900,787$34,537,0000.93%
Zebra Capital Management LLC 15,352$279,0000.82%
PFM Health Sciences, LP 1,177,250$21,391,0000.82%
EARNEST PARTNERS LLC 6,462,138$117,417,0000.78%
Glenview Capital Management 1,696,791$30,831,0000.77%
AIMZ Investment Advisors, LLC 42,085$765,0000.37%
Phocas Financial Corp. 127,949$2,325,0000.35%
Redhawk Wealth Advisors, Inc. 34,680$630,0000.29%
View complete list of MYRIAD GENETICS INC shareholders